Shionogi Files Early NDA For Flu Drug Peramivir, Aims For 3 Million User Annual Supply

Shionogi announced Nov. 4 the company filed a new drug application for influenza drug peramivir with Japan's Ministry of Health, Labor and Welfare in October. The early NDA submission came just three month after the Osaka-based company completed a Phase III study for the drug